Your browser doesn't support javascript.
loading
Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer.
Senguttuvan, Rosemary N; Santiago, Nicole Lugo; Han, Ernest S; Lee, Byrne; Lee, Stephen; Lin, Wei-Chien; Kebria, Mehdi; Hakim, Amy; Lin, Jeff F; Wakabayashi, Mark T; Ruel, Nora; Tinsley, Raechelle; Eng, Melissa; Stewart, Daphne B; Wang, Edward W; Paz, Benjamin I; Wu, Xiwei; Cho, Hyejin; Liang, Winnie S; Rodriguez-Rodriguez, Lorna; Cristea, Mihaela C; Raoof, Mustafa; Dellinger, Thanh H.
Afiliación
  • Senguttuvan RN; Division of Gynecologic Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center (COH), Duarte, CA, USA.
  • Santiago NL; Division of Gynecologic Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center (COH), Duarte, CA, USA.
  • Han ES; Division of Gynecologic Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center (COH), Duarte, CA, USA.
  • Lee B; Department of Surgery, Stanford, Stanford, CA, USA.
  • Lee S; Division of Gynecologic Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center (COH), Duarte, CA, USA.
  • Lin WC; Division of Gynecologic Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center (COH), Duarte, CA, USA.
  • Kebria M; Division of Gynecologic Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center (COH), Duarte, CA, USA.
  • Hakim A; Division of Gynecologic Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center (COH), Duarte, CA, USA.
  • Lin JF; Division of Gynecologic Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center (COH), Duarte, CA, USA.
  • Wakabayashi MT; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Ruel N; Biostatistics Core, City of Hope BRI, Duarte, CA, USA.
  • Tinsley R; Clinical Trials Office, COH, Duarte, CA, USA.
  • Eng M; Clinical Trials Office, COH, Duarte, CA, USA.
  • Stewart DB; Department of Medical Oncology, COH, Duarte, CA, USA.
  • Wang EW; Department of Medical Oncology, COH, Duarte, CA, USA.
  • Paz BI; Division of Surgical Oncology, Department of Surgery, COH, Duarte, CA, USA.
  • Wu X; Integrative Genomics Core, City of Hope Beckman Research Institute (BRI), Duarte, CA, USA.
  • Cho H; Integrative Genomics Core, City of Hope Beckman Research Institute (BRI), Duarte, CA, USA.
  • Liang WS; Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Rodriguez-Rodriguez L; Division of Gynecologic Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center (COH), Duarte, CA, USA.
  • Cristea MC; Department of Surgery, Stanford, Stanford, CA, USA.
  • Raoof M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Dellinger TH; Division of Gynecologic Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center (COH), Duarte, CA, USA. tdellinger@coh.org.
Ann Surg Oncol ; 30(13): 8144-8155, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37710139
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Hipertermia Inducida / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Hipertermia Inducida / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos